共 39 条
[1]
Chavassieux P(1993)Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study Osteoporos Int 3 97-102
[2]
Pastoureau P(1990)Glucocorticoid-induced osteoporosis: pathogenesis and management Ann Intern Med 112 352-364
[3]
Chapuy MC(2002)The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis Osteoporos Int 13 777-787
[4]
Delmas PD(2000)Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 993-1000
[5]
Meunier PJ(1997)Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis N Engl J Med. 337 382-387
[6]
Lukert BP(1998)Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group N Engl J Med 339 292-299
[7]
Raisz LG(1999)Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study Arthritis Rheum 42 2309-2318
[8]
Van Staa TP(2007)Teriparatide or alendronate in glucocorticoid-induced osteoporosis N Engl J Med 357 2028-2039
[9]
Leufkens HG(undefined)undefined undefined undefined undefined-undefined
[10]
Cooper C(undefined)undefined undefined undefined undefined-undefined